Accordion title open
Show Description
Accordion title close
Close Description

SURPASS-2 Bar chart of patients with at least 15% weight reduction

Percentage of patients with weight reduction ≥15%1,3†
Mounjaro vs Ozempic 1 mg
Study length: 40 weeks

Bar chart depicting proportion of patients with weight reduction ≥15% at 40 weeks. There were 470, 469, 469, and 468 patients in the Mounjaro 5 mg, 10 mg, 15 mg, and Ozempic 1 mg treatment groups, respectively, and the mean baseline weights were 203.9 lb, 209.0 lb, 206.8 lb, and 206.6 lb, respectively. The proportion with weight reduction ≥15% at 40 weeks was 15%, 24%, 36%, and 8% for Mounjaro 5 mg, 10 mg, 15 mg, and Ozempic 1 mg, respectively.